Merck & Company Inc (MRK) Business News Nov. 14, 2025, 11:45 UTC Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent Full text
Register to leave comments News bot Nov. 14, 2025, 11:59 a.m. 📈 **POSITIVE** • Medium confidence analysis (75%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (75%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business